LSWM
CVS icon

Lorne Steinberg Wealth Management’s CVS Health CVS Stock Holding History

Lorne Steinberg Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.82M Sell
108,854
-70
-0.1% -$5.39K 1.85% 27
2025
Q4 		$8.64M Buy
108,924
+80
+0.1% +$6.31K 1.99% 22
2025
Q3 		$8.21M Sell
108,844
-913
-0.8% -$62.6K 1.98% 20
2025
Q2 		$7.57M Sell
109,757
-320
-0.3% -$21K 1.98% 23
2025
Q1 		$7.46M Buy
110,077
+3,630
+3% +$217K 2.17% 15
2024
Q4 		$4.78M Sell
106,447
-610
-0.6% -$34.2K 1.39% 33
2024
Q3 		$6.73M Buy
107,057
+8,380
+8% +$489K 1.95% 22
2024
Q2 		$5.83M Buy
98,677
+935
+1% +$58.5K 1.88% 25
2024
Q1 		$7.8M Buy
97,742
+290
+0.3% +$22.2K 2.43% 11
2023
Q4 		$7.69M Sell
97,452
-120
-0.1% -$8.54K 2.59% 7
2023
Q3 		$6.81M Sell
97,572
-287
-0.3% -$20.3K 2.62% 7
2023
Q2 		$6.76M Buy
97,859
+22,348
+30% +$1.59M 2.55% 6
2023
Q1 		$5.61M Buy
75,511
+760
+1% +$63.7K 2.24% 17
2022
Q4 		$6.97M Buy
74,751
+480
+0.6% +$46.3K 2.99% 6
2022
Q3 		$7.08M Buy
74,271
+110
+0.1% +$10.9K 3.44% 2
2022
Q2 		$6.87M Buy
74,161
+420
+0.6% +$41K 3.23% 4
2022
Q1 		$7.46M Sell
73,741
-392
-0.5% -$41.2K 3.45% 3
2021
Q4 		$7.65M Sell
74,133
-495
-0.7% -$45.7K 3.29% 5
2021
Q3 		$6.33M Buy
74,628
+1,680
+2% +$141K 3.07% 7
2021
Q2 		$6.09M Buy
72,948
+1,475
+2% +$121K 2.99% 7
2021
Q1 		$5.38M Buy
71,473
+6,985
+11% +$509K 2.85% 11
2020
Q4 		$4.42M Buy
+64,488
New +$4.19M 2.75% 12

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lorne Steinberg Wealth Management's CVS Position: Q1 2026 in Review

Lorne Steinberg Wealth Management reduced its CVS Health (CVS) stake by 0.06% in Q1 2026, selling an estimated $5.39K and leaving 108,854 shares worth $7.82M. The position accounts for 1.85% of the portfolio, ranked #27.

Lorne Steinberg Wealth Management first reported a position in CVS in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.64M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Lorne Steinberg Wealth Management held 108,854 shares of CVS Health worth $7.82M as of Q1 2026.
  • Lorne Steinberg Wealth Management sold 70 CVS Health shares in Q1 2026, an estimated $5.39K.
  • CVS Health made up 1.85% of Lorne Steinberg Wealth Management's portfolio in Q1 2026, its #27 holding.
  • Lorne Steinberg Wealth Management first reported a position in CVS Health in Q4 2020 and has held it in 22 quarters since.
  • Lorne Steinberg Wealth Management's CVS Health position peaked at $8.64M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Lorne Steinberg Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.